NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.345
+0.085 (3.76%)
Jan 22, 2026, 1:21 PM EST - Market open
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $69.42 million as of January 22, 2026. Its market cap has increased by 113.61% in one year.
Market Cap
69.42M
Enterprise Value
69.98M
1-Year Change
113.61%
Ranking
Category
Stock Price
$2.35
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has increased from $65.80M to $69.42M, an increase of 5.51%. That is a compound annual growth rate of 0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 63.50M | -16.56% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeyondSpring | 69.91M |
| aTyr Pharma | 69.23M |
| Pelthos Therapeutics | 68.99M |
| Adlai Nortye | 67.53M |
| ImageneBio | 67.10M |
| InflaRx | 67.00M |
| CervoMed | 64.68M |
| Tevogen Bio Holdings | 64.09M |